Predict your next investment

Private Equity
ashhill.net

See what CB Insights has to offer

Investments

3

Portfolio Exits

1

About AshHill Investments

AshHill Pharmaceutical Investments is a private equity fund focused on investing in life sciences business opportunities. AshHill provides equity capital to both "seed-stage" and established companies with pharmaceutical and medical device platforms that target significant healthcare needs.

AshHill Investments Headquarter Location

20 North Grand Avenue Suite 700

Fort Thomas, Kentucky, 41075,

United States

859-309-6224

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest AshHill Investments News

AshHill et al. invest in Heart Metabolics

Jan 7, 2013

Save this article   Send to   US private equity firm AshHill Investments and Australian VC fund Trans Tasman Commercialisation Fund (TTCF) have invested $4m in London-based biotech company Heart Metabolics. The company will use the funding to advance US clinical development of perhexiline, its lead drug candidate for the treatment of heart failure symptoms in patients with hypertrophic cardiomyopathy (HCM).... To continue reading...

AshHill Investments Investments

3 Investments

AshHill Investments has made 3 investments. Their latest investment was in Armetheon as part of their Series A on August 8, 2014.

CBI Logo

AshHill Investments Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/28/2014

Series A

Armetheon

$7M

Yes

4

4/17/2014

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

1/3/2013

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/28/2014

4/17/2014

1/3/2013

Round

Series A

Series A - II

Series A

Company

Armetheon

Subscribe to see more

Subscribe to see more

Amount

$7M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

10

10

AshHill Investments Portfolio Exits

1 Portfolio Exit

AshHill Investments has 1 portfolio exit. Their latest portfolio exit was Armetheon on March 30, 2017.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/30/2017

Merger

1

Date

3/30/2017

Exit

Merger

Companies

Valuation

Acquirer

Sources

1

AshHill Investments Team

1 Team Member

AshHill Investments has 1 team member, including current Chief Operating Officer, Steven Smith.

Name

Work History

Title

Status

Steven Smith

Chief Operating Officer

Current

Name

Steven Smith

Work History

Title

Chief Operating Officer

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.